Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

NCT02543476 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02543476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02543476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 16, 2015
Completion date
November 14, 2016
Enrollment
412 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the head and neck